Multi‐national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome-Reference-Cited by-同舟云学术

Multi‐national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome

Published:2022-06-10 Issue:7 Volume:62 Page:1355-1364
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Vijenthira Abi¹^ORCID,Starkman Rebecca²,Lin Yulia³⁴^ORCID,Stanworth Simon J.⁵⁶⁷⁸,Bowen David⁹^ORCID,Harrison Lea¹⁰,Wintrich Sophie¹¹,Callum Jeannie³⁴,Buckstein Rena¹²

Affiliation:

1. Division of Medical Oncology and Hematology Princess Margaret Cancer Centre Toronto Ontario Canada

2. New York Medical College Valhalla New York USA

3. Department of Laboratory Medicine and Molecular Diagnostics Sunnybrook Health Sciences Centre Toronto Ontario Canada

4. Department of Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario Canada

5. Transfusion Medicine NHS Blood and Transplant Oxford UK

6. Department of Haematology Oxford University Hospitals NHS Foundation Trust Oxford UK

7. Radcliffe Department of Medicine University of Oxford Oxford UK

8. NIHR Oxford Biomedical Research Centre Oxford UK

9. Department of Hematology Leeds Teaching Hospitals Leeds United Kingdom

10. MDS Foundation Inc. Yardville New Jersey USA

11. MDS UK Patient Support Group London UK

12. MDS Research Program Sunnybrook Odette Cancer Center Toronto Ontario Canada

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16946

Reference26 articles.

1. The Myelodysplastic Syndromes: Diagnosis and Treatment

2. Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making

4. Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes

5. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome;Current Treatment Options in Oncology;2024-05-30

2. Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS‐M) prediction in myelodysplastic syndromes;Journal of Internal Medicine;2024-04-23

3. Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms;Cancers;2024-04-19

4. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE;Transfusion;2024-02

5. Rethinking the transfusion pathway in myelodysplastic syndromes: Study protocol for a novel randomized feasibility n‐of‐1 trial of weekly‐interval red cell transfusion in myelodysplastic syndromes;Transfusion;2024-01-12